Clinical Trial Update: Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa [Phase 4]

View source ↗

Summary

GlaxoSmithKline completed a Phase 4 epidemiology study on malaria transmission intensity in Sub-Saharan Africa. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria, Malaria Vaccines | Phase 4 | Status: COMPLETED | Results posted: 2025-07-24